JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells.

The M2 isoform of pyruvate kinase (PKM2), which has been identified as the predominant cause of the Warburg effect in cancer cells, is essential in tumor metabolism and growth. However, the role of PKM2 in autophagy remains to be elucidated. The present study investigated the effect of PKM2 knockdown on autophagy and apoptotic cell death in human A549 alveolar adenocarcinoma cells. Two short hairpin (sh)RNAs targeting human PKM2 mRNA were designed and lentiviral vectors were constructed. The A549 cells were infected with lentiviruses, containing shRNAs against PKM2, and the expression of PKM2 was examined by reverse transcription-quantitative polymerase chain reaction (RT‑qPCR) and immonoblotting analysis. A lactose dehydrogenase (LDH)‑coupled enzyme assay was used to detect the pyruvate kinase activity. RT‑qPCR was used to detect the mRNA expression level of glycolysis‑associated enzymes. The quantification of cells with punctate LC3 and expression of LC3II were examined to demonstrate autophagy. An MTT assay was used to detect cell viability and flow cytometry was used to determine cell apoptosis. The activity of caspase 3/7 and the expression of Bcl‑2 were also detected in A549 cells with PKM2 knockdown. The present study demonstrated that the two shRNAs efficiently downregulated the mRNA and protein expression levels of PKM2 in A549 cells. The knockdown of PKM2 decreased pyruvate kinase activity and glycolysis. Autophagy was induced in A549 cells with PKM2 knockdown. Inhibition of autophagy accelerated apoptotic death in PKM2‑knockdown cells and this was dependent on increased caspase 3/7 activity and decreased expression of Bcl‑2. In conclusion, the downregulation of PKM2 induced apoptosis and autophagy in A549 cells and this autophagy protected the cells from apoptotic cell death.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app